Journal of the Formosan Medical Association = Taiwan yi zhi · 2025
Survival, tachyarrhythmias and adverse cardiovascular outcomes in adult patients with Ebstein anomaly.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Chun-Wei, Wu Mei-Hwan, Chiu Shuenn-Nan, Wang Jou-Kou, Tseng Wei-Chieh, Chen Chun-An, Lin Ming-Tai
Аннотация
BACKGROUND: The clinical spectrum of adults with Ebstein anomaly (EA) is variable, influenced by interventions and aging.
OBJECTIVES: To assess long-term outcomes in adults with EA who survived into adulthood.
METHODS: This retrospective study analyzed 106 adults with EA treated between 1980 and 2022.
RESULTS: Of the 106 adults, 14 received definitive intervention in childhood and 34 in adulthood (2 underwent heart transplantation). Transplant-free survival by age 60 was 0.885 ± 0.061. Preexcitation was present in 32 patients (30.2 %), with 29 developing tachyarrhythmias, 11 of whom experienced them in adulthood. Ablation was successful in 23 patients (16 during adulthood). Excluding those who underwent childhood ablation, the incidence of adult-onset supraventricular tachycardia (SVT) was 15.6 % by age 40 and 20 % by age 50. Among patients with preexcitation, the incidence of adult-onset SVT reached 83.6 % by age 50. Adult-onset atrial tachyarrhythmias became more common with age, with incidences of 21.7 %, 37.5 %, and 58.9 % by ages 50, 60, and 70, respectively. These were not associated with preexcitation. Notably, none of the seven patients who underwent successful ablation in childhood developed atrial tachyarrhythmias. Adverse cardiovascular outcomes occurred in 9.1 %, 17.7 %, and 41.2 % of patients aged 18-39, 40-59, and 60+, respectively, with atrial tachyarrhythmias as the most significant predictor.
CONCLUSION: Adults with EA face a substantial risk of tachyarrhythmias and adverse cardiovascular outcomes, both of which increase with age. By age 50, the incidence of atrial tachyarrhythmias surpasses that of SVT and strongly predicts adverse cardiovascular outcomes.
OBJECTIVES: To assess long-term outcomes in adults with EA who survived into adulthood.
METHODS: This retrospective study analyzed 106 adults with EA treated between 1980 and 2022.
RESULTS: Of the 106 adults, 14 received definitive intervention in childhood and 34 in adulthood (2 underwent heart transplantation). Transplant-free survival by age 60 was 0.885 ± 0.061. Preexcitation was present in 32 patients (30.2 %), with 29 developing tachyarrhythmias, 11 of whom experienced them in adulthood. Ablation was successful in 23 patients (16 during adulthood). Excluding those who underwent childhood ablation, the incidence of adult-onset supraventricular tachycardia (SVT) was 15.6 % by age 40 and 20 % by age 50. Among patients with preexcitation, the incidence of adult-onset SVT reached 83.6 % by age 50. Adult-onset atrial tachyarrhythmias became more common with age, with incidences of 21.7 %, 37.5 %, and 58.9 % by ages 50, 60, and 70, respectively. These were not associated with preexcitation. Notably, none of the seven patients who underwent successful ablation in childhood developed atrial tachyarrhythmias. Adverse cardiovascular outcomes occurred in 9.1 %, 17.7 %, and 41.2 % of patients aged 18-39, 40-59, and 60+, respectively, with atrial tachyarrhythmias as the most significant predictor.
CONCLUSION: Adults with EA face a substantial risk of tachyarrhythmias and adverse cardiovascular outcomes, both of which increase with age. By age 50, the incidence of atrial tachyarrhythmias surpasses that of SVT and strongly predicts adverse cardiovascular outcomes.